Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tirzepatide”

163 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 163 results

Large-scale testing (Phase 3)Study completedNCT05412004
What this trial is testing

Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep Apnea

Who this might be right for
Obstructive Sleep ApneaObesity
Eli Lilly and Company 469
Very early researchLooking for participantsNCT06759701
What this trial is testing

Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study

Who this might be right for
DiabetesProstate Cancer
M.D. Anderson Cancer Center 30
Post-approval studies (Phase 4)Looking for participantsNCT06606821
What this trial is testing

The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease

Who this might be right for
Coronary Artery DiseaseCoronary Microvascular DysfunctionOverweight or Obesity+3 more
Tina Vilsbøll 124
Testing effectiveness (Phase 2)Study completedNCT03131687
What this trial is testing

Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Eli Lilly and Company 318
Large-scale testing (Phase 3)Study completedNCT04657003
What this trial is testing

Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight

Who this might be right for
Type 2 DiabetesOverweightObesity
Eli Lilly and Company 938
Large-scale testing (Phase 3)Study completedNCT05963022
What this trial is testing

Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO)

Who this might be right for
Type 2 Diabetes
Eli Lilly and Company 206
Not applicableNot Yet RecruitingNCT07156331
What this trial is testing

Research on Effects of Drugs on Body Composition and Function With Imaging in Diabetes

Who this might be right for
Type 2 Diabetes
Kristin Clemens 20
Large-scale testing (Phase 3)Study completedNCT04184622
What this trial is testing

Tirzepatide (LY3298176) in Participants With Obesity or Overweight

Who this might be right for
OverweightObesity
Eli Lilly and Company 2,539
Testing effectiveness (Phase 2)Active Not RecruitingNCT06643728
What this trial is testing

Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight

Who this might be right for
ObesityOverweight
Eli Lilly and Company 240
Early research (Phase 1)Study completedNCT03375463
What this trial is testing

Tirzepatide (LY3298176) in Healthy Participants

Who this might be right for
Healthy
Eli Lilly and Company 52
Testing effectiveness (Phase 2)Looking for participantsNCT06518837
What this trial is testing

Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer

Who this might be right for
Hormone Receptor-Positive Breast CancerHER2-Negative Breast Cancer
Rutgers, The State University of New Jersey 40
Post-approval studies (Phase 4)Not Yet RecruitingNCT07354880
What this trial is testing

Effect of Tirzepatide on Cardiovascular and Metabolic Parameters in Obese Adult Patients With Congenital Heart Disease

Who this might be right for
Obesity & OverweightAdult Congenital Heart Disease
University Medical Centre Ljubljana 30
Post-approval studies (Phase 4)Active Not RecruitingNCT06861439
What this trial is testing

GLP-1s to Enhance Lasting Optimal Weight

Who this might be right for
Obesity
Wake Forest University Health Sciences 40
Not applicableStudy completedNCT07203677
What this trial is testing

Comparative Effectiveness of Tirzepatide Versus Sitagliptin in Individuals at Cardiovascular Risk (TIRZSITA-CVOT)

Who this might be right for
Type2 Diabetes MellitusAtherosclerotic Cardiovascular Disease
Brigham and Women's Hospital 49,065
Large-scale testing (Phase 3)Study completedNCT05024032
What this trial is testing

Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN)

Who this might be right for
ObesityOverweightMetabolism and Nutrition Disorder
Eli Lilly and Company 210
Large-scale testing (Phase 3)Study completedNCT05822830
What this trial is testing

Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities

Who this might be right for
ObesityOverweight
Eli Lilly and Company 751
Early research (Phase 1)Study completedNCT03322631
What this trial is testing

Tirzepatide (LY3298176) in Japanese Participants With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Eli Lilly and Company 48
Large-scale testing (Phase 3)Looking for participantsNCT06937086
What this trial is testing

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Who this might be right for
Ulcerative ColitisObesity or Overweight
Eli Lilly and Company 350
Testing effectiveness (Phase 2)Active Not RecruitingNCT06965413
What this trial is testing

Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related Comorbidity

Who this might be right for
ObesityOverweightOverweight With One Weight Related Comorbidity
Hoffmann-La Roche 285
Large-scale testing (Phase 3)Active Not RecruitingNCT06047548
What this trial is testing

LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

Who this might be right for
OverweightObesity
Eli Lilly and Company 400
Load More Results